Document:

EX-10.38

 Exhibit 10.38 
 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. 
 STOCK INCENTIVE PLAN 

OPTION AWARD NOTICE 
 [Name of Optionee] 
 You have been awarded an option to purchase shares of
Common Stock of Allscripts Healthcare Solutions, Inc. (the “Company”), pursuant to the terms and conditions of the Allscripts Healthcare Solutions, Inc. 2011 Stock Incentive Plan (the “Plan”) and the Stock Option
Agreement (the “Agreement”). Copies of the Plan and the Agreement are attached hereto. Capitalized terms not defined herein shall have the meanings specified in the Plan or the Agreement. 

 

			
	Option:	  	You have been awarded a Nonqualified Stock Option to purchase from the Company [insert number] shares of its Common Stock, par value $0.01 per share, subject to adjustment as
provided in Section 3.4 of the Agreement.
		
	Option Date:	  	                    ,
            
		
	Exercise Price:	  	$             per share, subject to adjustment as provided in Section 3.4 of the Agreement.
		
	Vesting Schedule:	  	Except as otherwise provided in the Plan, the Agreement, any other written agreement between the Company and Optionee or any other plan of the Company (as such plan may be amended
from time to time), the Option shall vest (i) on the first anniversary of the Option Date with respect to one-fourth of the number of shares subject thereto on the Option Date, rounded down to the nearest whole share, (ii) on the second
anniversary of the Option Date with respect to an additional one-fourth of the number of Options subject thereto on the Option Date, rounded down to the nearest whole share, (ii) on the third anniversary of the Option Date with respect to an
additional one-fourth of the number of Options subject thereto on the Option Date, rounded down to the nearest whole share and (iv) on the fourth anniversary of the Option Date with respect to the remaining shares subject thereto on the Option
Date, provided you remain continuously employed by the Company or a Subsidiary through the applicable vesting date.
		
	Expiration Date:	  	Except to the extent earlier terminated pursuant to Section 2.2 of the Agreement or earlier exercised pursuant to Section 2.3 of the Agreement, the Option shall terminate
at 5:00 p.m., Chicago time, on the seventh anniversary of the Option Date.

			
	Acknowledgment, Acceptance and Agreement:	  	By accepting this award using the Company’s procedure for electronic acceptance, you acknowledge receipt of this Option Award Notice, the Agreement and the Plan, you accept the
Option granted hereunder and you agree to be bound by the terms and conditions of this Option Award Notice, the Agreement and the Plan. The Option shall be null and void until you accept this award using the Company’s procedure for electronic
acceptance.

  

			
	ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
		
	By:	 	  

	Name:
	Title:

  
 2 

 ALLSCRIPTS HEALTHCARE SOLUTIONS,
INC. 
 STOCK INCENTIVE PLAN 

STOCK OPTION AGREEMENT 

Allscripts Healthcare Solutions, Inc., a Delaware corporation (the “Company”), hereby grants to the individual
(“Optionee”) named in the Option Award Notice attached hereto (the “Award Notice”) as of the date set forth in the Award Notice (the “Option Date”), pursuant to the provisions of the Allscripts
Healthcare Solutions, Inc. 2011 Stock Incentive Plan (the “Plan”), an option to purchase from the Company the number and class of shares of stock set forth in the Award Notice at the price per share set forth in the Award Notice
(the “Exercise Price”) (the “Option”), upon and subject to the terms and conditions set forth below, in the Award Notice and in the Plan. For purposes of this Agreement, “Company” shall mean the
Company and any Subsidiary thereof, collectively and individually. Capitalized terms not defined herein shall have the meanings specified in the Plan. 
 1. Option Subject to Acceptance of Agreement. The Option shall be null and void unless Optionee shall accept this Agreement through the Company’s electronic acceptance procedures. 

2. Time and Manner of Exercise of Option. 
 2.1 Maximum Term of Option. In no event may the Option be exercised, in whole or in part, after the expiration date set forth in the Award Notice (the “Expiration Date”).

 2.2 Vesting and Exercise of Option. The Option shall become vested and exercisable in accordance with the vesting
schedule set forth in the Award Notice (the “Vesting Schedule”). The Option shall be vested and exercisable following a termination of Optionee’s employment according to the following terms and conditions: 

(a) Termination as a Result of Optionee’s Death or Disability. If Optionee’s employment with the Company terminates by
reason of Optionee’s death or Disability, then the Option, to the extent vested on the effective date of such termination of employment, may thereafter be exercised by Optionee or Optionee’s executor, administrator, legal representative,
guardian or similar person until and including the earlier to occur of (i) the date which is one year after the date of such termination of employment and (ii) the Expiration Date. 

(b) Termination Other than for Cause, Death or Disability. If Optionee’s employment with the Company is terminated for any
reason other than for Cause, death or Disability, the Option, to the extent vested on the effective date of such termination of employment, may thereafter be exercised by Optionee until and including the earlier to occur of (i) the date which
is ninety (90) days after the date of such termination of employment and (ii) the Expiration Date. 
 (c)
Termination by Company for Cause. If Optionee’s employment with the Company terminates by reason of the Company’s termination of Optionee’s employment for Cause, then the Option, whether or not vested, shall terminate
immediately upon such termination of employment. 

 (d) Disability. For purpose of this Option, “Disability” shall mean
Optionee’s inability to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous
period of not less than 12 months; provided, however, that if the term “Disability,” “disabled,” or a similar term is defined in an employment agreement between the Company and Optionee, the definition in the employment
agreement shall apply for purpose of this Option. 
 (e) Cause. For purposes of this Option, “Cause” shall mean
(i) the willful or grossly negligent failure by Optionee to perform his or her duties and obligations in any material respect, other than any such failure resulting from the disability of Optionee, (ii) Optionee’s conviction of a
crime or offense involving the property of the Company, or any crime or offense constituting a felony or involving fraud or moral turpitude; (iii) Optionee’s violation of any law, which violation is materially and demonstrably injurious to
the operations or reputation of the Company; or (iv) Optionee’s material violation of any generally recognized policy of the Company; provided, however, that if the term “Cause” is defined in an employment agreement between the
Company and Optionee, the definition in the employment agreement shall apply for purpose of this Option. 
 (f) Notwithstanding
the terms of this Section 2.2 and Section 3.5 below, in the event an employment agreement between the Company and Optionee provides terms and conditions for vesting and exercisability of the Option following termination of Optionee’s
employment and such terms and conditions conflict with with this Section 2.2 or Section 3.5, then the terms of such employment agreement shall govern this Option. 
 2.3 Method of Exercise. Subject to the limitations set forth in this Agreement, the Option may be exercised by Optionee (a) by giving written notice to the Company specifying the number of
whole shares of Common Stock to be purchased and accompanying such notice with payment therefor in full (or arrangement made for such payment to the Company’s satisfaction) either (i) in cash, (ii) by delivery to the Company (either
actual delivery or by attestation procedures established by the Company) of shares of Common Stock having a Fair Market Value, determined as of the date of exercise, equal to the aggregate purchase price payable by reason of such exercise,
(iii) by authorizing the Company to withhold whole shares of Common Stock which would otherwise be delivered having an aggregate Fair Market Value, determined as of the date of exercise, equal to the amount necessary to satisfy such obligation,
(iv) in cash by a broker-dealer acceptable to the Company to whom Optionee has submitted an irrevocable notice of exercise or (v) by a combination of (i), (ii) and (iii), and (b) by executing such documents as the Company may
reasonably request. Any fraction of a share of Common Stock which would be required to pay such purchase price shall be disregarded and the remaining amount due shall be paid in cash by Optionee. No shares of Common Stock shall be issued and no
certificate representing Common Stock shall be delivered until the full purchase price therefor and any withholding taxes thereon, as described in Section 3.3, have been paid (or arrangement made for such payment to the Company’s
satisfaction). 
 2.4 Termination of Option. In no event may the Option be exercised after it terminates as set forth in
this Section 2.4. The Option shall terminate, to the extent not earlier terminated pursuant to Section 2.2 or exercised pursuant to Section 2.3, on the Expiration Date. Upon the termination of the Option, the Option and all rights
hereunder shall immediately become null and void. 

  
 2 

 3. Additional Terms and Conditions of Option. 

3.1 Nontransferability of Option. The Option may not be transferred by Optionee other than by will or the laws of descent and
distribution, pursuant to the designation of one or more beneficiaries on the form prescribed by the Company or, to the extent permitted by the Company, to a trust or entity established by the Optionee for estate planning purposes, a charitable
organization designated by the Optionee or pursuant to a qualified domestic relations order, in each case, without consideration. Except to the extent permitted by the foregoing sentence, (i) during Optionee’s lifetime the Option is
exercisable only by Optionee or Optionee’s legal representative, guardian or similar person and (ii) the Option may not be sold, transferred, assigned, pledged, hypothecated, encumbered or otherwise disposed of (whether by operation of law
or otherwise) or be subject to execution, attachment or similar process. Upon any attempt to so sell, transfer, assign, pledge, hypothecate, encumber or otherwise dispose of the Option, the Option and all rights hereunder shall immediately become
null and void. 
 3.2 Investment Representation. Optionee hereby represents and covenants that (a) any shares of
Common Stock purchased upon exercise of the Option will be purchased for investment and not with a view to the distribution thereof within the meaning of the Securities Act of 1933, as amended (the “Securities Act”), unless the
subsequent sale has been registered under the Securities Act and any applicable state securities laws; (b) any subsequent sale of any such shares shall be made either pursuant to an effective registration statement under the Securities Act and
any applicable state securities laws, or pursuant to an exemption from registration under the Securities Act and such state securities laws; and (c) if requested by the Company, Optionee shall submit a written statement, in a form satisfactory
to the Company, to the effect that such representation (x) is true and correct as of the date of any purchase of any shares hereunder or (y) is true and correct as of the date of any sale of any such shares, as applicable. As a further
condition precedent to any exercise of the Option, Optionee shall comply with all regulations and requirements of any regulatory authority having control of or supervision over the issuance or delivery of the shares and, in connection therewith,
shall execute any documents which the Board or the Committee shall in its sole discretion deem necessary or advisable. 
 3.3
Withholding Taxes. (a) The Company shall have the right to require, prior to the issuance or delivery of any shares of Common Stock, upon the exercise of the Option, payment by Optionee of any federal, state, local or other taxes which
may be required to be withheld or paid in connection with such exercise of the Option (the “Required Tax Payments”). 
 (b) Optionee may satisfy his or her obligation to advance the Required Tax Payments by any of the following means: (1) a cash payment to the Company, (2) delivery (either actual delivery or by
attestation procedures established by the Company) to the Company of previously owned whole shares of Common Stock having an aggregate Fair Market Value, determined as of the Tax Date, equal to the Required Tax Payments, (3) authorizing the
Company to withhold whole shares of Common Stock which would otherwise be delivered or an 

  
 3 

 
amount of cash which would otherwise be payable to the Optionee having an aggregate Fair Market Value, determined as of the Tax Date, equal to the Required Tax Payments, (4) except as may be
prohibited by applicable law, a cash payment by a broker-dealer acceptable to the Company to whom Optionee has submitted an irrevocable notice of exercise or (5) any combination of (1), (2) and (3). Shares of Common Stock to be delivered
or withheld may not have an aggregate Fair Market Value in excess of the amount determined by applying the minimum statutory withholding rate. Any fraction of a share of Common Stock which would be required to satisfy such an obligation shall be
disregarded and the remaining amount due shall be paid in cash by Optionee. 
 3.4 Adjustment. In the event of any stock
split, stock dividend, recapitalization, reorganization, merger, consolidation, combination, exchange of shares, liquidation, spin-off or other similar change in capitalization or event, or any distribution to holders of Common Stock other than a
regular cash dividend, the terms of the Option, including the number and class of securities subject hereto and the Exercise Price, shall be appropriately adjusted by the Committee, such adjustments to be made without an increase in the aggregate
Exercise Price and in accordance with Section 409A of the Code. The decision of the Committee regarding any such adjustment shall be final, binding and conclusive. 
 3.5 Change in Control. Unless otherwise provided in another written agreement between Optionee and the Company, in the event of a Change in Control in which the successor company (including the
parent of any surviving corporation in a merger) assumes or substitutes the Option, if Optionee’s employment with such successor company (or a subsidiary thereof) is terminated within 24 months following such Change in Control (or within
three months prior thereto in connection with the Change in Control) without Cause by the Company or the successor company or by Optionee for Good Reason, all restrictions, limitations and other conditions applicable to the Option outstanding as of
the date of such termination of employment (or as of the date of the Change in Control if termination occurred prior to and in connection with the Change in Control) shall lapse and the Option shall become fully vested. 

(a) For purposes of this Section 3.5, “Good Reason” shall mean (i) any significant diminution in Optionee’s
responsibilities from and after the date of the Change in Control, (ii) any material reduction in the annual salary or target incentive cash compensation of Optionee from and after the date of the Change in Control or (iii) any requirement
after the date of the Change in Control (or prior thereto in connection with the Change in Control) to relocate to a location that is more than fifty (50) miles from the principal work location of Optionee; provided, however, that the
occurrence of any such condition shall not constitute Good Reason unless Optionee provides written notice to the Company of the existence of such condition not later than 90 days after the initial existence of such condition, and the Company
shall have failed to remedy such condition within 30 days after receipt of such notice; further provided, however, that if the term “Good Reason,” “Constructive Discharge,” or a similar term is defined in an employment
agreement between the Company and Optionee, the definition in the employment agreement shall apply for purpose of this Option. 

  
 4 

 3.6 Compliance with Applicable Law. The Option is subject to the condition that if
the listing, registration or qualification of the shares subject to the Option upon any securities exchange or under any law, or the consent or approval of any governmental body, or the taking of any other action is necessary or desirable as a
condition of, or in connection with, the purchase or issuance of shares hereunder, the Option may not be exercised, in whole or in part, and such shares may not be issued, unless such listing, registration, qualification, consent, approval or other
action shall have been effected or obtained, free of any conditions not acceptable to the Company. The Company agrees to use reasonable efforts to effect or obtain any such listing, registration, qualification, consent, approval or other action.

 3.7 Issuance or Delivery of Shares. Upon the exercise of the Option, in whole or in part, the Company shall issue or
deliver, subject to the conditions of this Section 3, the number of shares of Common Stock purchased against full payment therefor. Such issuance shall be evidenced by the appropriate entry on the books of the Company or of a duly authorized
transfer agent of the Company. The Company shall pay all original issue or transfer taxes and all fees and expenses incident to such issuance, except as otherwise provided in Section 3.3. 

3.8 Option Confers No Rights as Stockholder. Optionee shall not be entitled to any privileges of ownership with respect to shares
of Common Stock subject to the Option unless and until such shares are purchased and issued upon the exercise of the Option, in whole or in part, and Optionee becomes a stockholder of record with respect to such issued shares. Optionee shall not be
considered a stockholder of the Company with respect to any such shares not so purchased and issued. 
 3.9 Option Confers No
Rights to Continued Employment. In no event shall the granting of the Option or its acceptance by Optionee, or any provision of this Agreement or the Plan, give or be deemed to give Optionee any right to continued employment by the Company, any
Subsidiary or any affiliate of the Company or affect in any manner the right of the Company, any Subsidiary or any affiliate of the Company to terminate the employment of any person at any time. 

4. Miscellaneous Provisions. 
 4.1 Decisions of Board or Committee. The Board or the Committee shall have the right to resolve all questions which may arise in connection with the Option or its exercise. Any interpretation,
determination or other action made or taken by the Board or the Committee regarding the Plan, this Agreement or the Award Notice shall be final, binding and conclusive. 
 4.2 Successors. This Agreement shall be binding upon and inure to the benefit of any successor or successors of the Company and any person or persons who shall, upon the death of Optionee, acquire
any rights hereunder in accordance with this Agreement or the Plan. 
 4.3 Notices. All notices, requests or other
communications provided for in this Agreement shall be made, if to the Company, to Allscripts Healthcare Solutions, Inc., Attn: General Counsel, 222 Merchandise Mart Plaza, Suite 2024, Chicago, IL 60654, and if to 

  
 5 

 
Optionee, to the last known mailing address of Optionee contained in the records of the Company. All notices, requests or other communications provided for in this Agreement shall be made in
writing either (a) by personal delivery, (b) by facsimile or electronic mail with confirmation of receipt, (c) by mailing in the United States mails or (d) by express courier service. The notice, request or other communication
shall be deemed to be received upon personal delivery, upon confirmation of receipt of facsimile or electronic mail transmission or upon receipt by the party entitled thereto if by United States mail or express courier service; provided,
however, that if a notice, request or other communication sent to the Company is not received during regular business hours, it shall be deemed to be received on the next succeeding business day of the Company. 

4.4 Partial Invalidity. The invalidity or unenforceability of any particular provision of this Agreement shall not effect the
other provisions hereof and this Agreement shall be construed in all respects as if such invalid or unenforceable provisions were omitted. 
 4.5 Governing Law. This Agreement, the Option and all determinations made and actions taken pursuant hereto and thereto, to the extent not governed by the Code or the laws of the United States,
shall be governed by the laws of the State of Delaware and construed in accordance therewith without giving effect to principles of conflicts of laws. 
 4.6 Counterparts. The Award Notice may be executed in two counterparts, each of which shall be deemed an original and both of which together shall constitute one and the same instrument.

 4.7 Agreement Subject to the Plan. This Agreement is subject to the provisions of the Plan, and shall be interpreted
in accordance therewith. Optionee hereby acknowledges receipt of a copy of the Plan, and by accepting this Agreement in accordance with the Company’s electronic acceptance procedures, he or she agrees to be bound by the terms and conditions of
this Agreement, the Award Notice and the Plan. 

  
 6EX-10.39

 Exhibit 10.39 
 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. 
 Performance-Based Restricted
Stock Unit Award Agreement 
 Performance-Based Vesting – Relative TSR 

THIS AGREEMENT is made as of [            ] (the “Grant
Date”), by and between Allscripts Healthcare Solutions, Inc., a Delaware corporation (“Company”), and [            ] (the “Participant”). 

WHEREAS, the Participant is expected to perform valuable services for the Company and the Company considers it desirable and in
its best interests that the Participant be given a proprietary interest in the Company and an incentive to advance the interests of the Company by possessing units that are settled in shares of the Company’s Common Stock, $.01 par value per
share (the “Common Stock”), in accordance with the Company’s 2011 Stock Incentive Plan (the “Plan”). 

NOW THEREFORE, in consideration of the foregoing premises, it is agreed by and between the parties as follows: 

 

	1.	Grant of Performance-Based Restricted Stock Units. 

  

	 	(a)	Grant. Subject to the terms and conditions set forth in this Agreement and the Plan, the Company hereby grants to the Participant a target award of
[            ] performance-based restricted stock units (the “Performance-Based Restricted Stock Unit Award”), which shall vest and become unrestricted in accordance with
Section 2 hereof. 

  

	 	(b)	Transferability. Performance-based restricted stock units subject to the Performance-Based Restricted Stock Unit Award and not then vested and unrestricted may
not be sold, transferred, pledged, assigned, alienated, hypothecated, encumbered or otherwise disposed of (whether by operation of law or otherwise) or be subject to execution, attachment or similar process. Upon any attempt to so sell, transfer,
assign, pledge, alienate, hypothecate or encumber, or otherwise dispose of such performance-based restricted stock units, the Performance-Based Restricted Stock Unit Award shall immediately become null and void. 

 

	2.	Vesting. 

  

	 	(a)	Performance-Based Vesting. Subject to this Section 2, the Performance-Based Restricted Stock Unit Award shall vest and become unrestricted in accordance
with Exhibit A hereto. 

  

	 	(b)	 Accelerated Vesting for Termination following a Change in Control. In the event of a Change in Control (as defined in the Plan), (i) all
unearned performance-based restricted stock units subject to the Performance-Based Restricted Stock Unit Award shall be deemed to be earned based on relative TSR (as such term is

	 	
defined in Exhibit A hereto), the number of which shall be determined based on the market price of the Company’s Common Stock being the closing price on the date of the consummation of the
Change in Control and the market price of the Company’s Comparison Group (as such term is defined in Exhibit A hereto) being an average of the closing prices for the 30-day period ending five business days prior to such consummation, and
(ii) all such earned performance-based restricted stock units subject to the Performance-Based Restricted Stock Unit Award shall remain unvested and shall continue to vest in accordance with their original vesting schedule. If the
Participant‘s employment with such successor company (or a subsidiary thereof) is terminated within 24 months following such Change in Control (or within six months prior thereto in connection with the Change in Control) without Cause by the
Company or the successor company or by the Participant for Good Reason, all earned and unvested performance-based restricted stock units subject to the Performance-Based Restricted Stock Unit Award outstanding as of the date of such termination of
employment (or as of the date of the Change in Control if termination occurred prior to and in connection with the Change in Control) shall vest and be distributed. 

 

	 	(c)	Settlement of Performance-Based Restricted Stock Units. Upon the date performance-based restricted stock units subject to this Agreement become vested and
unrestricted, one share of Common Stock shall be issuable for each performance-based restricted stock unit that vests on such date, subject to the terms and conditions of the Plan and this Agreement. Thereafter, the Company will transfer such shares
of Common Stock to the Participant upon satisfaction of any required tax withholding obligations. 

  

	 	(d)	Other Defined Terms. 

Cause. “Cause” shall mean (i) the willful or grossly negligent failure by the Participant to perform his or her
duties and obligations in any material respect, other than any such failure resulting from the disability of the Participant, (ii) the Participant’s conviction of a crime or offense involving the property of the Company, or any crime or
offense constituting a felony or involving fraud or moral turpitude; (iii) the Participant’s violation of any law, which violation is materially and demonstrably injurious to the operations or reputation of the Company; or (iv) the
Participant’s material violation of any generally recognized policy of the Company; provided, however, that if the term “Cause” is defined in an employment agreement between the Company and the Participant, the definition in the
employment agreement shall apply for purpose of this Agreement. 
 Good Reason. “Good Reason” shall mean
(i) any significant diminution in the Participant’s responsibilities from and after the date of the Change in Control, (ii) any material reduction in the annual salary or target incentive cash compensation of the Participant from and
after the date of the Change in Control or (iii) any requirement after the date of the Change in Control (or prior thereto in connection with the Change in Control) to relocate to a location that is more than

  
 2 

 
fifty (50) miles from the principal work location of the Participant; provided, however, that the occurrence of any such condition shall not constitute Good Reason unless the Participant
provides written notice to the Company of the existence of such condition not later than 90 days after the initial existence of such condition, and the Company shall have failed to remedy such condition within 30 days after receipt of such notice.

  

	3.	No Rights as Stockholder; Dividend Equivalents. The Participant shall not have any rights of a stockholder of the Company with respect to any shares of
Common Stock issuable upon the vesting of performance-based restricted stock units subject to this Agreement (including the right to vote and to receive dividends and other distributions paid with respect to shares of Common Stock), unless and
until, and only to the extent, the Performance-Based Restricted Stock Unit Award is settled by the issuance of such shares of Common Stock to the Participant. Notwithstanding the foregoing, at such time as the restrictions lapse, an amount equal to
any cash dividends that would have been payable to the Participant if the shares of Common Stock underlying the performance-based restricted stock units subject to this Agreement had been issued to the Participant during the restriction period shall
be paid in cash to the Participant with respect to the actual number of performance-based restricted stock units that have vested. This Section 3 will not apply with respect to record dates for dividends occurring prior to the Grant Date or
after the restriction period has lapsed. 

  

	4.	Termination of Employment. 

  

	 	(a)	Subject to Section 2 and Sections 4(b) and 4(c), if the Participant’s employment with the Company (or an affiliate of the Company if such affiliate is the
Participant’s employer) is terminated other than due to death and other than by the Company due to the Disability (as defined below) of the Participant, the performance-based restricted stock units subject to the Performance-Based Restricted
Stock Unit Award which are unearned as of the date of termination shall be forfeited by the Participant and such performance-based restricted stock units shall be cancelled by the Company. 

 

	 	(b)	Subject to Section 2 and Section 4(c), if the Participant’s employment with the Company (or an affiliate of the Company if such affiliate is the
Participant’s employer) is terminated due to the death or Disability of the Participant, the performance-based restricted stock units subject to the Performance-Based Restricted Stock Unit Award which are unearned as of the date of termination
shall be deemed to be earned at 100% of target level and the number of performance-based restricted stock units so earned shall vest and be distributed. 

  

	 	(c)	If, on the date the Participant’s employment terminates, there is a written employment agreement in place between the Participant and the Company (or between the
Participant and an affiliate of the Company if such affiliate is the Participant’s employer), then, in the event of a conflict, the terms of such written employment agreement regarding vesting upon termination shall prevail over the terms of
this Agreement (it being understood that any accelerated vesting shall be subject to the satisfaction of the performance conditions as described herein and be based on the level achieved hereunder). 

  
 3 

	 	(d)	“Disability” shall mean the Participant’s being “disabled” as defined in Treas. Reg. §1.409A-3(i)(4)(i). 

 

	5.	Adjustment in Event of Happening of Condition. 

 In the event that there is any change in the number of issued shares of Common Stock of the Company without new consideration to the Company (such as by stock dividends or stock split-ups), then the
number of unvested performance-based restricted stock units subject to this Performance-Based Restricted Stock Unit Award shall be adjusted in proportion to such change in issued shares. 

If the outstanding shares of Common Stock of the Company shall be combined, or be changed into another kind of stock of the Company or
into equity securities of another corporation, whether through recapitalization, reorganization, sale, merger, consolidation, etc., the Company shall cause adequate provision to be made whereby the unvested performance-based restricted stock units
subject to this Agreement shall be adjusted equitably so that the securities received upon vesting shall be the same as if the vesting had occurred immediately prior to such recapitalization, reorganization, sale, merger, consolidation, etc.

 Notwithstanding the foregoing, in the event of a sale of the Company through a merger, consolidation or sale of all or
substantially all of its assets where all or part of the consideration is stock, cash or other securities or property (a “Transaction”), the Performance-Based Restricted Stock Unit Award shall be assumed or an award of equivalent value
shall be substituted by the successor corporation or a parent or subsidiary of the successor corporation in an economically equivalent manner. In the event that the successor corporation refuses or is unable to assume or substitute for the
Performance-Based Restricted Stock Unit Award in an economically equivalent manner, then simultaneously with the consummation of the Transaction, the Participant shall fully vest in the Performance-Based Restricted Stock Unit Award at the level
deemed to be earned in accordance with Section 2(b) of this Agreement and such number of performance-based restricted stock units subject to the Performance-Based Restricted Stock Unit Award shall become unrestricted. For the purposes of this
Section 5, the Performance-Based Restricted Stock Unit Award shall be considered assumed in an economically equivalent manner only if, following the Transaction, the Performance-Based Restricted Stock Unit Award confers the right to receive,
for each performance-based restricted stock unit subject to the Performance-Based Restricted Stock Unit Award and unvested immediately prior to the Transaction, publicly traded shares of common stock of the successor company substantially equal in
fair market value to the per share consideration received by holders of shares of Common Stock in the Transaction. The determination of such substantial equality of value of consideration shall be made by the Committee in its sole discretion and its
determination shall be conclusive and binding. 

  
 4 

	6.	No Right to Continued Employment. This Agreement shall not be construed as giving the Participant the right to be retained in the employ of the Company.

  

	7.	Provisions of Plan. This Performance-Based Restricted Stock Unit Award is granted pursuant to, and subject to the terms and conditions of, the Plan (which
is incorporated herein by reference). In the event a provision of this Agreement conflicts with the Plan, the terms of the Plan will prevail. the Participant acknowledges receiving a copy of the Plan and this Agreement. Any capitalized term not
defined herein shall have the same meaning as in the Plan. 

  

	8.	Withholding of Taxes; Section 409A. The Company shall be entitled, if necessary or desirable, to withhold from any amounts due and payable by the
Company to the Participant (or to secure payment from the Participant in lieu of withholding) the amount of any withholding or other tax due from the Company (“Required Tax Payments”) with respect to any performance-based restricted stock
units which become vested and unrestricted under this Agreement, and the Company may defer issuance of Common Stock underlying such performance-based restricted stock units until such amounts are paid or withheld. The Participant shall satisfy his
or her Required Tax Payments by any of the following means: (1) a cash payment to the Company, (2) delivery (either actual delivery or by attestation procedures established by the Company) to the Company of previously owned whole shares of
Common Stock (for which the Participant has good title, free and clear of all liens and encumbrances) having a Fair Market Value (as defined in the Plan), determined as of the date the obligation to withhold or pay taxes first arises in connection
with the Performance-Based Restricted Stock Unit Award (the “Tax Date”), equal to the Required Tax Payments, (3) authorizing the Company to withhold from the shares of Common Stock otherwise to be delivered to the holder pursuant to
the Performance-Based Restricted Stock Unit Award, a number of whole shares of Common Stock having a Fair Market Value, determined as of the Tax Date, equal to the Required Tax Payments, (4) a cash payment by a broker-dealer acceptable to the
Company through whom the Participant has sold the shares with respect to which the Required Tax Payments have arisen or (5) any combination of (1), (2) and (3). The Compensation Committee shall have sole discretion to disapprove of an
election pursuant to any of clauses (2)-(5) for any holder who is not an “officer” (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934). Unless and until the Company determines otherwise, the method in clause
(3) above shall be utilized. Shares of Common Stock to be delivered or withheld may not have a Fair Market Value in excess of the minimum amount of the Required Tax Payments. Any fraction of a share of Common Stock which would be required to
satisfy such an obligation shall be disregarded and the remaining amount due shall be paid in cash by the holder. No certificate representing a share of Common Stock shall be delivered until the Required Tax Payments have been satisfied in full.

 It is intended that any amounts payable under this Performance-Based Restricted Stock Unit Award comply with the
provisions of Code Section 409A of the Internal Revenue Code of 1986 and the treasury regulations relating thereto so as not to subject the Participant to the payment of interest and tax penalty which may be imposed under Code
Section 409A. In furtherance of this interest, to the extent that any regulations or other 

  
 5 

 
guidance issued under Code Section 409A after the date of this Performance-Based Restricted Stock Unit Award would result in the Participant being subject to payment of interest and tax
penalty under Code Section 409A, the parties agree to amend this Performance-Based Restricted Stock Unit Award in order to bring this Performance-Based Restricted Stock Unit Award into compliance with Code Section 409A. No amount shall be
payable pursuant to a termination of the Participant’s employment unless such termination constitutes a separation from service under Section 409A. To the extent any amounts payable upon the Participant’s separation from service are
nonqualified deferred compensation under Section 409A, and if the Participant is at such time a specified employee under Section 409A, then to the extent required under Section 409A payment of such amounts shall be postponed until six
(6) months following the date of the Participant’s separation from service (or until any earlier date of the Participant death), upon which date all such postponed amounts shall be paid to the Participant in a lump sum, and any remaining
payments due shall be paid as otherwise provided herein. The determination of whether the Participant is a specified employee shall made by the Company in accordance with Section 409A. 

 

	9.	Binding Effect. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective heirs, executors, administrators,
successors and assigns. 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed
on the day and year first above written. 
  

			
	ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
		
	By:	 	  

	Name:	 	  

	  

		 	[            ]

  
 6 

 Exhibit A 
 1. For purposes of this Exhibit: 
  

	 	•	 	 The maximum number of performance-based restricted stock units subject to this Agreement is 200% of the target number of
[            ], of which up to 33 1/3% shall be eligible for vesting with respect to attainment of the Performance Measure in each of the three Performance
Periods (as such term is defined below), as set forth below but subject to the Alternative Three Year Performance Period Vested Unit Calculation (as such term is defined below). 

 

	 	•	 	 The “Performance Measure” is relative “Total Shareholder Return” (as such term is defined below) for each Performance Period.

 Following the end of each Performance Period, the Company’s Compensation Committee will certify the
level of the Performance Measure achieved by the Company for such Performance Period. The performance-based restricted stock units subject to vesting during a Performance Period will be subject to forfeiture and cancellation by the Company if the
Company’s performance during such Performance Period does not meet or exceed the threshold percentile rank of the Performance Measure for such Performance Period. Performance at or above the threshold level will result performance-based
restricted stock units becoming vested as set forth below, and shares underlying such vested performance-based restricted stock units shall be distributed following completion of the certification described above. 

Notwithstanding the foregoing, following completion of the three-year period commencing on the Grant Date and ending on the third
anniversary of the Grant Date (the “Three Year Performance Period”), the Compensation Committee will determine the number of performance-based restricted stock units that would vest if the maximum number of performance-based restricted
stock units subject to the Performance-Based Restricted Stock Unit Award had been subject only to the Three Year Performance Period (the “Alternative Three Year Performance Period Vested Unit Calculation”). If the number of
performance-based restricted stock units that vest pursuant to the Alternative Three Year Performance Period Vested Unit Calculation is greater than the number of performance-based restricted stock units that vest under this Agreement in the three
Performance Periods described herein without regard to the Alternative Three Year Performance Period Vested Unit Calculation, then such greater number of performance-based restricted stock units shall vest pursuant to the Alternative Three Year
Performance Period Vested Unit Calculation, reduced by the number of performance-based restricted stock units previously vested. Shares underlying vested performance-based restricted stock units shall be distributed following completion of the
certification described above. 
 2. Additional Definitions. 

a. “Comparison Group” means the companies listed on Appendix 1 to this Exhibit A, as may be adjusted as described below.

 b. “Performance Period” means each of the following three periods: 

  
 A-1

	 	(i)	the one-year period commencing on the Grant Date and ending on the first anniversary of the Grant Date, 

 

	 	(ii)	the two-year period commencing on the Grant Date and ending on the second anniversary of the Grant Date, and 

 

	 	(iii)	the three-year period commencing on the Grant Date and ending on the third anniversary of the Grant Date. 

c. “Total Shareholder Return” or “TSR” means total shareholder return as applied to the Company or any company in the Comparison
Group, meaning stock price appreciation from the beginning to the end of the Performance Period, plus dividends and distributions made or declared (assuming such dividends or distributions are reinvested in the common stock of the Company or any
company in the Comparison Group) during the Performance Period, expressed as a percentage return. Except as modified in Section 4(d), for purposes of computing TSR, the stock price at the beginning of the Performance Period will be the
average price of a share of common stock over the 30 trading days ending on the first day of the Performance Period, and the stock price at the end of the Performance Period will be the average price of a share of common stock over the 30 trading
days ending on the last day of the Performance Period, adjusted for changes in capital structure; provided, however, that TSR will be negative one hundred percent (-100%) if a company: (i) files for bankruptcy, reorganization, or
liquidation under any chapter of the U.S. Bankruptcy Code; (ii) is the subject of an involuntary bankruptcy proceeding that is not dismissed within 30 days; (iii) is the subject of a stockholder approved plan of liquidation or
dissolution; or (iv) ceases to conduct substantial business operations. 
 3. Calculation. For purposes of the award,
the number of shares earned will be calculated as follows: 
 FIRST: For the Company and for each other company in the
Comparison Group, determine the TSR for the Performance Period. 
 SECOND: Rank the TSR values determined in the first step from
low to high (with the company having the lowest TSR being ranked number 1, the company with the second lowest TSR ranked number 2, and so on) and determine the Company’s percentile rank based upon its position in the list by dividing the
Company’s position by the total number of companies (including the Company) in the Comparison Group and rounding the quotient to the nearest hundredth. For example, if the Company were ranked 60 on the list out of 80 companies (including the
Company), its percentile rank would be 75%. 
 THIRD: Plot the percentile rank for the Company determined in the second step
into the appropriate band in the left-hand column of the table below and determine the number of shares earned as a percent of target, which is the figure in the right-hand column of the table below corresponding to that percentile rank. Use linear
interpolation between points in the table below to determine the percentile rank and the corresponding share funding if the Company’s percentile rank is greater than     % and less than     % but not
exactly one of the percentile ranks listed in the left-hand column. For example, if the Company’s percentile rank is     %, then     % of target shares would be earned. 

  
 A-2

									
	 	  	Relative
TSR %ile
Rank	 	  	Shares
Earned
as % Target	 
	 Maximum
	  	 	—P	  	  	 	200	% 
		  	 	—P	  	  	 	—	% 
		  	 	—P	  	  	 	—	% 
	 Target
	  	 	—P	  	  	 	100	% 
		  	 	—P	  	  	 	—	% 
		  	 	—P	  	  	 	—	% 
	 Threshold
	  	 	—P	  	  	 	—	% 

  

	 	•	 	 Linear interpolation for performance between points shown 

 

	 	•	 	 Payout is capped at 100% if absolute Company’s TSR is negative 

 

	 	•	 	 Payout value capped at 5x target each period 

 4. Rules. The following rules apply to the computation of the number of shares earned: 
 a. If the Company’s absolute TSR is negative over any of the three Performance Periods, payouts shall not exceed 100% of target for that Performance Period. The aggregate value of the shares earned
and settled in each Performance Period, based on the Fair Market Value of such shares as of the date of settlement, shall not exceed five (5) times the target payment value for such performance period. 

b. The minimum earnout is zero and the maximum earnout is 200% of target. There is no minimum number of shares or other consideration
that recipient will receive, and no shares will be earned if the percentile rank is          percentile or lower in a Performance Period. 

c. For purposes of computing Total Shareholder Return for the Company and each other company in the Comparison Group, the stock price at
the beginning and end of the Performance Period will, subject to Section 2 of the Performance-Based Restricted Stock Unit Award Agreement, be determined as the 30-day average closing price of the stock on each of the 30 consecutive
trading days ending on and including the first day or last day of the Performance Period, as the case may be. 
 d. Companies
shall be removed from the Comparison Group if they undergo a Specified Corporate Change. A company that is removed from the Comparison Group before the measurement date will not be included at all in the computation of the performance factor. A
company in the Comparison Group will be deemed to have undergone a “Specified Corporate Change” if it: 
  

	 	1.	ceases to be a domestically domiciled publicly traded company on a national stock exchange or market system, unless such cessation of such listing is due to a low stock
price or low trading volume; or 

  
 A-3

	 	2.	has gone private; or 

  

	 	3.	has reincorporated in a foreign (e.g., non-U.S.) jurisdiction, regardless of whether it is a reporting company in that or another jurisdiction; or

  

	 	4.	has been acquired by another company (whether by a peer company or otherwise, but not including internal reorganizations), or has sold all or substantially all of its
assets. 

 The Company shall rely on press releases, public filings, website postings, and other reasonably
reliable information available regarding a peer company in making a determination that a Specified Corporate Change has occurred. 

  
 A-4

 Appendix 1 to 
 Exhibit A to 
 Performance-Based Stock Unit Agreement 

Comparison Group 
  

					
	ACI Worldwide	  	Informatica	  	Tyler Technologies
	Acxiom	  	j2 Global Comm	  	Ultimate Software
	Advent Software	  	Jack Henry & Assoc	  	ValueClick
	Ancestry.com	  	JDA Software	  	Vantiv
	AOL	  	Kenexa	  	VeriFone Systems
	Aspen Technology	  	Lender Processing	  	Verint Systems
	athenahealth	  	Liquidity Services	  	VirnetX Holding
	Bankrate	  	Manhattan Assoc	  	Wright Express
	Blackbaud	  	Maxims	  	Zynga
	Booz Allen Hamilton	  	McKesson	  	
	Broadridge Fin	  	MedAssets	  	
	CACI Intl	  	Medidata Solutions	  	
	Cadence Design Sys	  	Mentor Graphics	  	
	Cardtronics	  	Merge Healthcare	  	
	Catamaran	  	MICROS Systems	  	
	Cerner	  	Millennial Media	  	
	CommVault Systems	  	NetScout Systems	  	
	Computer Progs & Sys	  	NeuStar	  	
	Compuware	  	OpenTable	  	
	Concur Tech	  	Parametric Tech	  	
	Convergys	  	Progress Software	  	
	CoreLogic	  	Qlik Technologies	  	
	Cornerstone OnDemand	  	Quality Sys	  	
	CoStar Group	  	Quest Software	  	
	DealerTrack Hldgs	  	RealPage	  	
	DST Systems	  	Rovi	  	
	Euronet Worldwide	  	Sapient	  	
	Exact Target	  	Solera Hldgs	  	
	Fair Issac	  	Sourcefire	  	
	Fortinet	  	Splunk	  	
	Genpact	  	SS&C Tech Hldgs	  	
	Global Payments	  	Syntel	  	
	Guidewire Software	  	Take-Two Interactive	  	
	Heartland Payment	  	TiVo

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00213-of-00352.parquet"}]]